Acurx Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company developing antibiotics to treat bacterial infections. Its lead candidate is ibezapolstat to treat patients with clostridium difficile infections. Acurx is also developing ACX-375C, a treatment targeting gram-positive bacteria, including methicillin-resistant staphylococcus aureus, vancomycin-resistant enterococcus, and penicillin-resistant streptococcus pneumoniae. Acurx Pharmaceuticals was incorporated in 2017 and is headquartered in Staten Island, NY.
What is Acurx Pharmaceuticals's quote symbol?
What is the 52 week high and low for Acurx Pharmaceuticals (NASDAQ: ACXP)?
How much is Acurx Pharmaceuticals stock worth today?
How much is Acurx Pharmaceuticals's stock price per share?
What is Acurx Pharmaceuticals's Market Cap?